Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > A few questions, a few answers
View:
Post by canadafan on Aug 11, 2023 1:09pm

A few questions, a few answers

Someone asked about M.M. Being discussed?
Answer yes.
There is a study underway & they are anticipating results, soon. I can't be more specific than that. As that topic was briefly discussed & answer to the interviewer asking about other opportunities.
The whole gambit of additional, very important information, would appear to be forthcoming.
That being between end Sept & some conference october.
They were extremely vague on Panc cancer PanCan trial. Other than to say they are still engaging conversations with various pharma, as part of the Pancreatic trial invite.
Enrolment numbers were mentioned, Various trial details. 
additional, waiting for readouts from other Goblet trials. 

I have listened to 99% of Onc presentations. over many years.
This one was the leaste conclusive on anything.
The only very firm thing they said was " the majority of the recent $15million share offering, was picked up by a medical interst"
that?
could be a pharma company, murtual fund, or a very wealthy Dr.?
again, lots of mysteries.
great weekend all.
Monday is Q2 update.
hopefully more answers by then.

Comment by jimsenior on Aug 11, 2023 2:16pm
Thanks canadafan. Least conclusive may be a good thing. I shall get to that in a minute. I have not seen so many longs truly pi$$ed off in quite some time. MC has obfuscated for years and his time to exit has come. NOW. The MM trial is likely BMS with opdivo, not AMBUSH which is another trial. I think there may be 2 other older trials still active, but not them either. Hofmeister liked what he ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities